Australia is the ideal location for early phase clinical/phase I studies
Save time, minimize costs, generate internationally accepted date ready for the next phase.
FASTER OUTCOMES
WORLD-CLASS QUALITY
LOWER COSTS
Trusted by leading biotech and pharmaceutical companies, as well as local government and industry organizations.
We Understand the Power of Conducting Clinical Trial in Australia
With Resolian you get a bioanalytical partner who understands the Australian life sciences ecosystem. Resolian’s state-of-the-art Brisbane lab will provide support for your clinical trials in a timely and efficient manner with our world-class team and high-quality data.
We know what it takes to be successful in Australia.
Our network of trusted professionals and partners will support you with study design, clinical management, regulatory advice, finance, accounting, company set-up and much more.
Advantages of Conducting Clinical Trial in Australia
Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development.
Our state-of-the-art bioanalytical facility supports pre-clinical and clinical testing in Brisbane, Australia.
No IND Required
Our biotech clients start their Phase I without having to wait for an IND, saving up to a year in regulatory processing times and considerable costs.
Fast. 4-5 Week Start Up
For HREC approval (dependent on site).
Save Money. 43.5% rebate.
Biotechs can save 43.5% with the Australian Government’s attractive rebate to support clinical trials in Australia for organizations that establish an Australian entity.
At least 60% cheaper than the US.
World-Class Data.
Resolian data generated in Australia is accepted by all the major regulatory authorities including the FDA and EMA.
State-of-the-art Facilites.
Industry-leading bioanalytical lab located in Brisbane. Accredited by NATA.
Seamless Clinical Development Support with Resolian.
We can transfer your assays across the globe.
Together with global labs in the US, the UK, and China, your journey starts with phase I in Australia and extends seamlessly across the globe for your subsequent phase II or III trials.
Why Partner With Resolian?
We are bioanalytical experts.
Resolian is a global bioanalytical partner offering seamless assay transfer to the US, UK, or China, ensuring continued support beyond Phase 1 clinical trials in Australia for a cost-effective and efficient drug development process.
Trusted by pharmaceutical and biotech companies of all sizes and at any stage of the drug development process.
Resolian has been supporting international biotechs in their clinical drug development processes for regulatory approval for the past two decades.
Expert Bioanalytical Services in Australia
We offer a range of assays and services to support drug development in Australia, from pre-clinical to late-phase.
CASE STUDY:
From Contract to First Patient in 12 Weeks: Resolian Delivers on Tight Timeline
A Chinese biotech study sponsor is conducting a clinical trial in AUS. The contract was signed in the November, and the First Patient In (FPI) was in early February.
CHALLENGES
- Four methods to be developed and validated before FPI
- Export reference materials and internal standards from China to Australia
- Timely Communication
- Language Barrier
SOLUTIONS
- Resolian’s Chongqing lab started method development while preparing shipping documents, which saved 3-4 weeks for the Brisbane lab to complete Method Development / Method Validation
- Chongqing Lab took care of export and shipping documents for the sponsor
- A direct message group with 2-way translation was implemented to facilitate easy communication and timely response
- Assigned a Chinese-speaking Project Manager to work with all stakeholders to avoid potential barrier
CONCLUSION
All methods were validated on time and the study was completed successfully!
Working with Resolian means gaining
ACCESS TO A TRULY GLOBAL TEAM
Harmonizing lab processes and organizational structure across sites to provide a single global experience
Sharing scientific and technical expertise to ensure your projects are successful
A FAST AND EFFICIENT CRO
Get work done quickly with Resolian as the team enables concise collaboration with partners.
A TRUE PARTNER
Resolian’s team of experts works closely with clients to develop customized solutions for each specific program requirements.
GETTING STARTED IS SIMPLE
step 1:
Schedule a call
In a commitment-free consultation, we’ll meet with you to understand the challenges you’re facing.
step 2:
Receive a proposal
As an experienced, and industry leading, bioanalytical lab, Resolian will create a proposal that is as unique as your project.
We’ll be able to guide you through the Australian Clinical Trial Notification (CTN) Process and connect you to the right partners for every step.
step 3:
Rest assured knowing your project is in great hands
Resolian’s approach is to deliver high-quality results and ensuring compliance with regulatory requirements.
FAST TRACK YOUR EARLY PHASE CLINICAL TRIALS IN AUSTRALIA
In this visual podcast we explore why Australia is an attractive destination for early-phase clinical trials, highlighting the benefits of speed, quality, and cost-effectiveness.
The expert panel discussion delves into Australia’s unique regulatory pathways, the R&D tax incentives, operational logistics, and how early-phase data supports global drug development.
Watch the podcast today
Please enter the required details to watch the podcast.
